查看购物车
  • Traditional Chinese
  • English
  • Japanese
北美肠内和肠外医疗营养市场预测至 2028 年 - 按适应症、营养类型、形式、产品类型、给药途径、年龄层和配销通路进行的区域分析
市场调查报告书
商品编码
1375202

北美肠内和肠外医疗营养市场预测至 2028 年 - 按适应症、营养类型、形式、产品类型、给药途径、年龄层和配销通路进行的区域分析

North America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication, Nutrition Type, Form, Product Type, Route of Administration, Age Group, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 217 Pages | 订单完成后即时交付

价格

北美肠内和肠外医疗营养市场预计将从2023年的804998万美元增长到2028年的1103078万美元。预计2023年至2028年复合年增长率为6.5%。

胃肠道疾病盛行率上升推动北美肠内和肠外医疗营养市场

克罗恩病、肠阻塞、溃疡性结肠炎、短肠症候群、显微镜下结肠炎和某些癌症是胃肠道疾病的一些例子。

根据 2019 年全球疾病负担研究，2019 年全球记录了约 490 万例发炎性肠道疾病 (IBD) 病例；中国（911,405例）和美国（762,890例）的病例数最多，盛行率分别为每10万人中66.9例和245.3例。克隆氏症和溃疡性结肠炎是两种常见的 IBD。克罗恩病是一种复杂的慢性疾病，主要影响消化系统。这是北美最常见的疾病。此外，每年每 100 万人中约有 3 人患有短肠症候群 (SBS)。根据 2020 年发表的题为「了解短肠症候群：现况与未来展望」的文章，SBS 的盛行率在过去 40 年中增加了两倍多。在美国，盛行率约为每百万人 30 例。

患有胃肠道疾病的患者营养恶化的风险较高，因为他们被要求在接受诊断测试之前禁食。他们也可能因治疗性饮食限製而面临营养恶化，以及厌食症或营养需求改变引起的食慾不振，这可能是疾病本身造成的。因此，建议对胃肠道疾病患者进行医学营养，因为这些患者无法摄取食物。因此，优选肠内和肠外途径来为它们提供必需的营养。肠内餵食是指直接经由口腔或经由消化道（口腔到胃/小肠，然后肛门）的管子摄取食物营养。这种类型的营养优选为患有慢性疾病的患者提供治疗支持，例如神经系统疾病、胃肠道疾病和遗传性代谢疾病。有些人可能不适合插管，这使得满足他们的卡路里和营养需求变得困难。在这种情况下，优选肠外营养，以确保他们的身体保持水分并满足维持身体健康和功能所需的热量和其他营养摄取量。当患者因癌症和影响胃肠道的慢性疾病等疾病而无法满足营养需求时，需要肠外营养。这种营养是大多数严重 SBS 患者治疗的基石。因此，胃肠道疾病盛行率的上升推动了北美肠内和肠外医疗营养市场的成长。

北美肠内及肠外医疗营养市场概况

北美肠内和肠外医疗营养市场已细分为美国和加拿大。到2022年，美国将占据更大的市场份额。慢性病盛行率的上升、市场参与者不断发展的策略发展以及对肠内和肠外营养的日益偏好都有助于该地区的市场进步。此外，人们对医疗营养（例如管饲）在治疗慢性疾病方面的益处的了解不断增加，进一步促进了市场的成长。

北美肠内及肠外医疗营养市场收入及 2028 年预测（百万美元）

北美肠内和肠外医疗营养市场细分

北美肠内和肠外医疗营养市场分为适应症、营养类型、形式、产品类型、给药途径、年龄层、配销通路和国家。

根据适应症，北美肠内和肠外医疗营养市场分为老年人、胃肠道疾病、糖尿病、癌症、呼吸系统疾病、阿兹海默症、失智症、肾臟疾病、肝衰竭、covid-19后和其他适应症。 2023年，老年族群在北美肠内和肠外医疗营养市场中占据最大份额。胃肠道疾病分为IBD、IBS等。

根据营养类型，北美肠内和肠外医疗营养市场分为补充来源和单一来源。 2023年，补充品细分市场在北美肠内和肠外医疗营养市场中占有更大份额。

根据形式，北美肠内和肠外医疗营养市场分为液体、粉末和半固体。 2023年，液体细分市场占据北美肠内和肠外医疗营养市场的最大份额。

根据产品类型，北美肠内和肠外医疗营养市场分为一般和特定疾病。 2023年，普通细分市场在北美肠内和肠外医疗营养市场中占据最大份额。

根据给药途径，北美肠内和肠外医疗营养市场分为口服、管饲和肠外。 2023年，肠外细分市场占据北美肠内和肠外医疗营养市场的最大份额。

依年龄组，北美肠内和肠外医疗营养市场分为60岁以上、18-60岁、3-18岁及3岁以下。 2023年，60岁以上细分市场占据北美肠内和肠外医疗营养市场的最大份额。

根据配销通路，北美肠内和肠外医疗营养市场分为医院药房、零售店、电子商务等。 2023年，医院药局部门在北美肠内和肠外医疗营养市场中占据最大份额

根据国家/地区，北美肠内和肠外医疗营养市场分为美国和加拿大。 2023年，美国在北美肠内和肠外医疗营养市场份额中占据主导地位。

雅培实验室； B.布劳恩公司；百特国际公司；费森尤斯·卡比股份公司；麦迪卡营养公司； Medtrition 公司；雀巢公司；纽迪西亚国际有限公司；和 Nutrisens SAS 是北美肠内和肠外医疗营养市场的领先公司。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 北美肠内和肠外医疗营养市场 - 按适应症
    • 北美肠内和肠外医疗营养市场 - 按营养类型
    • 北美肠内和肠外医疗营养市场 - 按形式
    • 北美肠内和肠外医疗营养市场 - 按产品类型
    • 北美肠内和肠外医疗营养市场 - 按给药途径
    • 北美肠内和肠外医疗营养市场 - 按年龄组
    • 北美肠内和肠外医疗营养市场 - 按配销通路
    • 北美肠内和肠外医疗营养市场 - 按国家/地区

第 2 章：要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美肠内和肠外医疗营养市场 - 市场格局

  • 概述
  • 北美 PEST 分析
  • 专家意见
  • 能量含量分析
    • 低于 1.5 kcal/ml
    • 等于 1.5 kcal/ml
    • 低于2kcal/ml：
    • 等于或高于2kcal/ml：

第 5 章：北美肠内和肠外医疗营养市场 - 主要市场动态

  • 市场驱动因素
    • 胃肠道疾病盛行率上升
    • 营养不良和早产病例增加
  • 市场限制
    • 与肠内和肠外餵食系统相关的机械、胃肠道和代谢併发症，以及与导管放置相关的限制
  • 市场机会
    • 公司不断推出策略倡议
  • 未来的趋势
    • 特定配方和植物性营养产品
  • 影响分析

第 6 章：肠内和肠外医疗营养市场 - 北美分析

  • 北美肠内及肠外医疗营养市场收入预测与分析

第 7 章：北美肠内和肠外医疗营养市场 - 收入和 2028 年预测 - 按适应症

  • 概述
  • 北美肠内和肠外医疗营养市场收入份额，按适应症 2022 年和 2028 年 (%)
  • 老年
  • 胃肠道疾病
  • 糖尿病
  • 癌症
  • 呼吸系统疾病
  • 阿兹海默氏症
  • 失智
  • 肾臟疾病
  • 肝衰竭
  • 新冠肺炎 (COVID-19) 后
  • 其他适应症

第 8 章：北美肠内和肠外医疗营养市场 - 收入和 2028 年预测 - 按营养类型

  • 概述
  • 北美肠内和肠外医疗营养市场收入份额，按营养类型 2022 年和 2028 年 (%)
  • 补充
  • 唯一来源

第 9 章：北美肠内和肠外医疗营养市场 - 收入和 2028 年预测 - 按表格

  • 概述
  • 北美肠内和肠外医疗营养市场收入份额，按 2022 年和 2028 年表格 (%)
  • 液体
  • 粉末
  • 半固态

第 10 章：北美肠内和肠外医疗营养市场 - 收入和 2028 年预测 - 按产品类型

  • 概述
  • 2022 年和 2028 年北美肠内和肠外医疗营养市场收入份额（按产品类型划分）
  • 一般的
  • 特定疾病

第 11 章：北美肠内和肠外医疗营养市场 - 收入和 2028 年预测 - 按给药途径

  • 概述
  • 北美肠内和肠外医疗营养市场收入份额，按给药途径 2022 年和 2028 年 (%)
  • 口服
  • 管饲
  • 注射用

第 12 章：北美肠内和肠外医疗营养市场 - 收入和 2028 年预测 - 按年龄组

  • 概述
  • 北美肠内和肠外医疗营养市场收入份额，按年龄组 2022 年和 2028 年 (%)
  • 60岁以上
  • -60年
  • 3-18岁
  • 3岁以下

第 13 章：北美肠内和肠外医疗营养市场 - 收入和 2028 年预测 - 按配销通路

  • 概述
  • 北美肠内和肠外医疗营养市场收入份额，按配销通路2022 年和 2028 年 (%)
  • 医院药房
  • 零售店
  • 电子商务
  • 其他的

第 14 章：北美肠内和肠外医疗营养市场 - 收入和 2028 年预测 - 国家分析

  • 概述

第 15 章：北美肠内和肠外医疗营养市场 - 产业格局

  • 概述
  • 北美肠内和肠外医疗营养市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 16 章：公司简介

  • Abbott Laboratories
  • Nestle SA
  • Nutricia International BV
  • Medtrition Inc
  • Fresenius Kabi AG
  • B. Braun SE
  • Nutrisens SAS
  • Baxter International Inc
  • Medica Nutrition Inc

第 17 章：附录

  • 关于 Insight Partners
  • 专业术语
Product Code: BMIRE00028875

The North America enteral and parenteral medical nutrition market is expected to grow from US$ 8,049.98 million in 2023 to US$ 11,030.78 million by 2028. It is estimated to grow at a CAGR of 6.5% from 2023 to 2028.

Rise in Prevalence of Gastrointestinal Diseases Fuels North America Enteral and Parenteral Medical Nutrition Market

Crohn's disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancers are a few examples of gastrointestinal diseases.

Based on the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019; China (911,405) and the US (762,890) had the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Crohn's disease and ulcerative colitis are two of the commonly diagnosed IBDs. Crohn's disease is a complex, chronic disorder primarily affecting the digestive system. It is the most common disease in North America. Moreover, short bowel syndrome (SBS) occurs in ~3 per 1 million people yearly. As per the article titled "Understanding Short Bowel Syndrome: Current Status and Future Perspectives," published in 2020, the prevalence of SBS has increased by more than twofold in the last 40 years. The prevalence was ~30 cases per million in the US.

Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They may also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirement, which can be a result of the disease itself. Thus, medical nutrition is recommended for gastrointestinal disease patients as these patients cannot ingest food. Thus, the enteral and parenteral routes are preferred to provide them with essential nutrients. Enteral feeding refers to food nutrition intake directly through the mouth or through a tube that passes the digestive tract (mouth to stomach/small intestine and then anus). This type of nutrition is preferred to provide treatment support for patients suffering from chronic ailments, such as neurological disorders, gastrointestinal diseases, and inherited metabolic diseases. Some people may not show compatibility toward tube insertion, which makes meeting their calorie and nutrient needs difficult. In such cases, parenteral nutrition is preferred to ensure their bodies remain hydrated and meet the calorie and other nutrient intake required to maintain physical well-being and function. Parenteral nutrition is indicated when patients cannot meet their nutritional needs due to diseases, such as cancer and chronic diseases affecting the gastrointestinal tract. This type of nutrition is the cornerstone of therapy for most patients with severe SBS. Therefore, the elevating prevalence of gastrointestinal diseases drives the growth of the North America enteral and parenteral medical nutrition market.

North America Enteral and Parenteral Medical Nutrition Market Overview

The enteral and parenteral medical nutrition market in North America has been segmented into the US and Canada. The US held a larger share of the market in 2022. The rising prevalence of chronic diseases, growing strategic developments by market players, and increasing preference for enteral and parenteral nutrition contribute to the market progress in this region. Moreover, an upsurge in knowledge among individuals about the benefits of medical nutrition, such as tube feeding, in the treatment of chronic health conditions further contributes to the market growth.

North America Enteral and Parenteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

North America Enteral and Parenteral Medical Nutrition Market Segmentation

The North America enteral and parenteral medical nutrition market is segmented into indication, nutrition type, form, product type, route of administration, age group, and distribution channel, and country.

Based on indication, the North America enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer's disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023. Gastrointestinal disorders are segmented into IBD, IBS, and others.

Based on nutrition type, the North America enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held a larger share of the North America enteral and parenteral medical nutrition market in 2023.

Based on form, the North America enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.

Based on product type, the North America enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.

Based on route of administration, the North America enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.

Based on age group, the North America enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023.

Based on distribution channel, the North America enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest share of the North America enteral and parenteral medical nutrition market in 2023

Based on country, the North America enteral and parenteral medical nutrition market is segmented into the US and Canada. The US dominated the share of the North America enteral and parenteral medical nutrition market in 2023.

Abbott Laboratories; B. Braun SE; Baxter International Inc; Fresenius Kabi AG; Medica Nutrition Inc; Medtrition Inc; Nestle SA; Nutricia International BV; and Nutrisens SAS are some of the leading companies operating in the North America enteral and parenteral medical nutrition market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America enteral and parenteral medical nutrition market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in North America enteral and parenteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Enteral and Parenteral Medical Nutrition Market - By Indication
    • 1.3.2 North America Enteral and Parenteral Medical Nutrition Market - By Nutrition Type
    • 1.3.3 North America Enteral and Parenteral Medical Nutrition Market - By Form
    • 1.3.4 North America Enteral and Parenteral Medical Nutrition Market - By Product Type
    • 1.3.5 North America Enteral and Parenteral Medical Nutrition Market - By Route of Administration
    • 1.3.6 North America Enteral and Parenteral Medical Nutrition Market - By Age Group
    • 1.3.7 North America Enteral and Parenteral Medical Nutrition Market - By Distribution Channel
    • 1.3.8 North America Enteral and Parenteral Medical Nutrition Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Enteral and Parenteral Medical Nutrition Market - Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
  • 4.3 Experts Opinion
  • 4.4 Energy Content Analysis
    • 4.4.1 Lower than 1.5 kcal/ml
    • 4.4.2 Equals to 1.5 kcal/ml
    • 4.4.3 Lower than 2kcal/ml:
    • 4.4.4 Equal to or Higher than 2kcal/ml:

5. North America Enteral and Parenteral Medical Nutrition Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Gastrointestinal Diseases
    • 5.1.2 Increasing Cases of Malnutrition and Premature Births
  • 5.2 Market Restraints
    • 5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Enteral and Parenteral Feeding Systems, and Limitations Related to Catheter Placement
  • 5.3 Market Opportunities
    • 5.3.1 Growing Strategic Initiatives by Companies
  • 5.4 Future Trends
    • 5.4.1 Specific Formulations and Plant-Based Nutrition Products
  • 5.5 Impact Analysis

6. Enteral and Parenteral Medical Nutrition Market - North America Analysis

  • 6.1 North America Enteral and Parenteral Medical Nutrition Market Revenue Forecast and Analysis

7. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Indication

  • 7.1 Overview
  • 7.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
  • 7.3 Elderly
    • 7.3.1 Overview
    • 7.3.2 Elderly: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
  • 7.4 Gastrointestinal Disorders
    • 7.4.1 Overview
    • 7.4.2 Gastrointestinal Disorders: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
    • 7.4.3 Inflammatory Bowel Disease
      • 7.4.3.1 Overview
      • 7.4.3.2 IBD: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.3.2.1 North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
    • 7.4.4 Irritable Bowel Syndrome
      • 7.4.4.1 Overview
      • 7.4.4.2 IBS: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.4.2.1 North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
    • 7.4.5 Others
      • 7.4.5.1 Overview
      • 7.4.5.2 Others: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.5.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
  • 7.5 Diabetes
    • 7.5.1 Overview
    • 7.5.2 Diabetes: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.5.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
  • 7.6 Cancer
    • 7.6.1 Overview
    • 7.6.2 Cancer: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
  • 7.7 Respiratory Disorders
    • 7.7.1 Overview
    • 7.7.2 Respiratory Disorders: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.7.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form, 2020-2028 (US$ Million)
  • 7.8 Alzheimer's Disease
    • 7.8.1 Overview
    • 7.8.2 Alzheimer's Disease: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form, 2020-2028 (US$ Million)
  • 7.9 Dementia
    • 7.9.1 Overview
    • 7.9.2 Dementia: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.9.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
  • 7.10 Renal Disease
    • 7.10.1 Overview
    • 7.10.2 Renal Disease: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.10.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
  • 7.11 Liver Failure
    • 7.11.1 Overview
    • 7.11.2 Liver Failure: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.11.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
  • 7.12 Post COVID-19
    • 7.12.1 Overview
    • 7.12.2 Post COVID-19: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.12.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
  • 7.13 Other Indications
    • 7.13.1 Overview
    • 7.13.2 Other Indications: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.13.2.1 North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)

8. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Nutrition Type

  • 8.1 Overview
  • 8.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
  • 8.3 Supplemental
    • 8.3.1 Overview
    • 8.3.2 Supplemental: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Sole Source
    • 8.4.1 Overview
    • 8.4.2 Sole Source: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Form

  • 9.1 Overview
  • 9.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
  • 9.3 Liquid
    • 9.3.1 Overview
    • 9.3.2 Liquid: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Powder
    • 9.4.1 Overview
    • 9.4.2 Powder: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Semi-Solid
    • 9.5.1 Overview
    • 9.5.2 Semi-Solid: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Product Type

  • 10.1 Overview
  • 10.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
  • 10.3 General
    • 10.3.1 Overview
    • 10.3.2 General: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Disease Specific
    • 10.4.1 Overview
    • 10.4.2 Disease Specific: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Route of Administration

  • 11.1 Overview
  • 11.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
  • 11.3 Oral
    • 11.3.1 Overview
    • 11.3.2 Oral: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Tube Feed
    • 11.4.1 Overview
    • 11.4.2 Tube Feed: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Parenteral
    • 11.5.1 Overview
    • 11.5.2 Parenteral: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

12. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Age Group

  • 12.1 Overview
  • 12.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
  • 12.3 Above 60 Years
    • 12.3.1 Overview
    • 12.3.2 Above 60 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.4-60 Years
    • 12.4.1 Overview
    • 12.4.2-60 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.5 3-18 Years
    • 12.5.1 Overview
    • 12.5.2 3-18 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.6 Below 3 Years
    • 12.6.1 Overview
    • 12.6.2 Below 3 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

13. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Distribution Channel

  • 13.1 Overview
  • 13.2 North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
  • 13.3 Hospital Pharmacies
    • 13.3.1 Overview
    • 13.3.2 Hospital Pharmacies: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.4 Retail Stores
    • 13.4.1 Overview
    • 13.4.2 Retail Stores: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.5 E-Commerce
    • 13.5.1 Overview
    • 13.5.2 E-Commerce: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.6 Others
    • 13.6.1 Overview
    • 13.6.2 Others: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

14. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - Country Analysis

  • 14.1 Overview
      • 14.1.1.1 US: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 14.1.1.1.1 Overview
        • 14.1.1.1.2 US: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 14.1.1.1.3 US: North America Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
        • 14.1.1.1.3.1 US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
        • 14.1.1.1.3.2 US: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form
        • 14.1.1.1.3.3 US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.3.1 US: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.3.2 US: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.3.3 US: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.4 US: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.5 US: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.6 US: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.7 US: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.8 US: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.9 US: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.10 US: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.11 US: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.3.12 US: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.4 US: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
        • 14.1.1.1.5 US: North America Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
        • 14.1.1.1.6 US: North America Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
        • 14.1.1.1.7 US: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
        • 14.1.1.1.8 US: North America Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
        • 14.1.1.1.9 US: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
      • 14.1.1.2 Canada: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 14.1.1.2.1 Overview
        • 14.1.1.2.2 Canada: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 14.1.1.2.3 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
        • 14.1.1.2.3.1 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
        • 14.1.1.2.3.2 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.3 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.3.1 Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.3.2 Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.3.3 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.4 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.5 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.6 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.7 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.8 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.9 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.10 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.11 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.3.12 Canada: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.4 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
        • 14.1.1.2.5 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
        • 14.1.1.2.6 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
        • 14.1.1.2.7 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
        • 14.1.1.2.8 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
        • 14.1.1.2.9 Canada: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)

15. North America Enteral and Parenteral Medical Nutrition Market - Industry Landscape

  • 15.1 Overview
  • 15.2 Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market
  • 15.3 Inorganic Growth Strategies
    • 15.3.1 Overview
  • 15.4 Organic Growth Strategies
    • 15.4.1 Overview

16. Company Profiles

  • 16.1 Abbott Laboratories
    • 16.1.1 Key Facts
    • 16.1.2 Business Description
    • 16.1.3 Products and Services
    • 16.1.4 Financial Overview
    • 16.1.5 SWOT Analysis
    • 16.1.6 Key Developments
  • 16.2 Nestle SA
    • 16.2.1 Key Facts
    • 16.2.2 Business Description
    • 16.2.3 Products and Services
    • 16.2.4 Financial Overview
    • 16.2.5 SWOT Analysis
    • 16.2.6 Key Developments
  • 16.3 Nutricia International BV
    • 16.3.1 Key Facts
    • 16.3.2 Business Description
    • 16.3.3 Products and Services
    • 16.3.4 Financial Overview
    • 16.3.5 SWOT Analysis
    • 16.3.6 Key Developments
  • 16.4 Medtrition Inc
    • 16.4.1 Key Facts
    • 16.4.2 Business Description
    • 16.4.3 Products and Services
    • 16.4.4 Financial Overview
    • 16.4.5 SWOT Analysis
    • 16.4.6 Key Developments
  • 16.5 Fresenius Kabi AG
    • 16.5.1 Key Facts
    • 16.5.2 Business Description
    • 16.5.3 Products and Services
    • 16.5.4 Financial Overview
    • 16.5.5 SWOT Analysis
    • 16.5.6 Key Developments
  • 16.6 B. Braun SE
    • 16.6.1 Key Facts
    • 16.6.2 Business Description
    • 16.6.3 Products and Services
    • 16.6.4 Financial Overview
    • 16.6.5 SWOT Analysis
    • 16.6.6 Key Developments
  • 16.7 Nutrisens SAS
    • 16.7.1 Key Facts
    • 16.7.2 Business Description
    • 16.7.3 Products and Services
    • 16.7.4 Financial Overview
    • 16.7.5 SWOT Analysis
    • 16.7.6 Key Developments
  • 16.8 Baxter International Inc
    • 16.8.1 Key Facts
    • 16.8.2 Business Description
    • 16.8.3 Products and Services
    • 16.8.4 Financial Overview
    • 16.8.5 SWOT Analysis
    • 16.8.6 Key Developments
  • 16.9 Medica Nutrition Inc
    • 16.9.1 Key Facts
    • 16.9.2 Business Description
    • 16.9.3 Products and Services
    • 16.9.4 Financial Overview
    • 16.9.5 SWOT Analysis
    • 16.9.6 Key Developments

17. Appendix

  • 17.1 About The Insight Partners
  • 17.2 Glossary of Terms

List Of Tables

  • Table 1. North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. North America Enteral and Parenteral Medical Nutrition Market, For Others by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. US: North America Enteral and Parenteral Medical Nutrition Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. US: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. US: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. US: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. US: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. US: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. US: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. US: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. US: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. US: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. US: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. US: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. US: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. US: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. US: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. US: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. US: North America Enteral and Parenteral Medical Nutrition Market, by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. US: North America Enteral and Parenteral Medical Nutrition Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. US: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. US: North America Enteral and Parenteral Medical Nutrition Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. US: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Elderly by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBD by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Canada: North America Enteral and Parenteral Medical Nutrition Market, For IBS by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Others by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Cancer by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Dementia by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Canada: North America Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Nutrition Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Form - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Canada: North America Enteral and Parenteral Medical Nutrition Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Recent Inorganic Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market
  • Table 60. Recent Organic Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market
  • Table 61. Glossary of Terms

List Of Figures

  • Figure 1. North America Enteral and Parenteral Medical Nutrition Market Segmentation
  • Figure 2. North America Enteral and Parenteral Medical Nutrition Market, By Country
  • Figure 3. North America Enteral and Parenteral Medical Nutrition Market Overview
  • Figure 4. Elderly Segment Held Largest Share of Indication Segment in North America Enteral and Parenteral Medical Nutrition Market
  • Figure 5. The US is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 7. North America: PEST Analysis
  • Figure 8. Experts Opinion
  • Figure 9. Impact Analysis
  • Figure 10. North America Enteral and Parenteral Medical Nutrition Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 11. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
  • Figure 12. Elderly: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Gastrointestinal Disorders: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. IBD: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. IBS: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Others: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Diabetes: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Cancer: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Respiratory Disorders: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Alzheimer's Disease: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Dementia: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Renal Disease: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Liver Failure: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Post COVID-19: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Other Indications: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
  • Figure 27. Supplemental: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Sole Source: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
  • Figure 30. Liquid: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Powder: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Semi-Solid: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
  • Figure 34. General: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Disease Specific: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
  • Figure 37. Oral: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Tube Feed: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Parenteral: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
  • Figure 41. Above 60 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42.-60 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. 3-18 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Below 3 Years: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. North America Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
  • Figure 46. Hospital Pharmacies: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Retail Stores: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. E-Commerce: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Others: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. North America Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 51. North America Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 52. US: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Canada: North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Growth Strategies in the North America Enteral and Parenteral Medical Nutrition Market